Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 7948345, 8 pages
http://dx.doi.org/10.1155/2016/7948345
Research Article

2-Methoxyestradiol Alleviates Experimental Autoimmune Uveitis by Inhibiting Lymphocytes Proliferation and T Cell Differentiation

1Department of Ophthalmology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200092, China
2Shanghai Tenth People’s Hospital, Tongji University School of Medicine, 301 Middle Yanchang Road, Shanghai 200092, China

Received 30 January 2016; Revised 26 March 2016; Accepted 4 April 2016

Academic Editor: Shigeru Kotake

Copyright © 2016 Linxinyu Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. A. Jabs, R. B. Nussenblatt, J. T. Rosenbaum et al., “Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop,” American Journal of Ophthalmology, vol. 140, no. 3, pp. 509–516, 2005. View at Google Scholar
  2. R. W. J. Lee and A. D. Dick, “Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation,” Eye, vol. 26, no. 1, pp. 17–28, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. L. M. Cortes, M. J. Mattapallil, P. B. Silver et al., “Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2 b) and B10.RIII (H-2 r) mice,” Investigative Ophthalmology and Visual Science, vol. 49, no. 5, pp. 1946–1956, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Luger, P. B. Silver, J. Tang et al., “Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category,” The Journal of Experimental Medicine, vol. 205, no. 4, pp. 799–810, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Jäger, V. Dardalhon, R. A. Sobel, E. Bettelli, and V. K. Kuchroo, “Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes,” Journal of Immunology, vol. 183, no. 11, pp. 7169–7177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Amadi-Obi, C.-R. Yu, X. Liu et al., “TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1,” Nature Medicine, vol. 13, no. 6, pp. 711–718, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Peters, L. A. Pitcher, J. M. Sullivan et al., “Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation,” Immunity, vol. 35, no. 6, pp. 986–996, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. R. R. Caspi, “A look at autoimmunity and inflammation in the eye,” The Journal of Clinical Investigation, vol. 120, no. 9, pp. 3073–3083, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. T. M. LaVallee, X. H. Zhan, C. J. Herbstritt, E. C. Kough, S. J. Green, and V. S. Pribluda, “2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors α and β,” Cancer Research, vol. 62, no. 13, pp. 3691–3697, 2002. View at Google Scholar · View at Scopus
  10. D. Escuin, E. R. Kline, and P. Giannakakou, “Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1α accumulation and activity by disrupting microtubule function,” Cancer Research, vol. 65, no. 19, pp. 9021–9028, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. V. S. Pribluda, E. R. Gubish Jr., T. M. Lavallee, A. Treston, G. M. Swartz, and S. J. Green, “2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate,” Cancer and Metastasis Reviews, vol. 19, no. 1-2, pp. 173–179, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. T. E. Sutherland, R. L. Anderson, R. A. Hughes et al., “2-Methoxyestradiol—a unique blend of activities generating a new class of anti-tumour/anti-inflammatory agents,” Drug Discovery Today, vol. 12, no. 13-14, pp. 577–584, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. A. C. Issekutz and K. Sapru, “Modulation of adjuvant arthritis in the rat by 2-methoxyestradiol: an effect independent of an anti-angiogenic action,” International Immunopharmacology, vol. 8, no. 5, pp. 708–716, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. G. S. Duncan, D. Brenner, M. W. Tusche et al., “2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 51, pp. 21034–21039, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. R. K. Agarwal, C.-C. Chan, B. Wiggert, and R. R. Caspi, “Pregnancy ameliorates induction and expression of experimental autoimmune uveitis,” Journal of Immunology, vol. 162, no. 5, pp. 2648–2654, 1999. View at Google Scholar · View at Scopus
  16. D. Berg, R. Sonsala, and E. Kuss, “Concentrations of 2-methoxyoestrogens in human serum measured by a heterologous immunoassay with an 125I-labeled ligand,” Acta Endocrinologica, vol. 103, no. 2, pp. 282–288, 1983. View at Google Scholar · View at Scopus
  17. J.-I. Huh, H. Q. Ting, G. V. R. Chandramouli et al., “2-Methoxyestradiol induces mammary gland differentiation through amphiregulin-epithelial growth factor receptor-mediated signaling: molecular distinctions from the mammary gland of pregnant mice,” Endocrinology, vol. 148, no. 3, pp. 1266–1277, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. R. K. Agarwal, P. B. Silver, and R. R. Caspi, “Rodent models of experimental autoimmune uveitis,” Methods in Molecular Biology, vol. 900, pp. 443–469, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. W. P. Chong, R. Horai, M. J. Mattapallil et al., “IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses,” Journal of Autoimmunity, vol. 50, pp. 12–22, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Prete, R. Dammacco, M. C. Fatone, and V. Racanelli, “Autoimmune uveitis: clinical, pathogenetic, and therapeutic features,” Clinical and Experimental Medicine, 2015. View at Publisher · View at Google Scholar
  21. N. J. Mabjeesh, D. Escuin, T. M. LaVallee et al., “2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF,” Cancer Cell, vol. 3, no. 4, pp. 363–375, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. F. H. W. Shand, S. Y. Langenbach, C. R. Keenan et al., “In vitro and in vivo evidence for anti-inflammatory properties of 2-methoxyestradiol,” Journal of Pharmacology and Experimental Therapeutics, vol. 336, no. 3, pp. 962–972, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Zepp, L. Wu, and X. Li, “IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease,” Trends in Immunology, vol. 32, no. 5, pp. 232–239, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Zou, M. Adachi, K. Imai et al., “2-Methoxyestradiol, an endogenous mammalian metabolite, radiosensitizes colon carcinoma cells through c-Jun NH2-terminal kinase activation,” Clinical Cancer Research, vol. 12, no. 21, pp. 6532–6539, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. P. G. Hogan, L. Chen, J. Nardone, and A. Rao, “Transcriptional regulation by calcium, calcineurin, and NFAT,” Genes and Development, vol. 17, no. 18, pp. 2205–2232, 2003. View at Publisher · View at Google Scholar · View at Scopus